Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) NSE

1,693.50

+14.4(+0.86%)

Updated at October 20 11:07AM

Currency In INR

Valuation

Market Cap4.07T
Enterprise Value3.98T
P/E Ratio39.16
PEG Ratio-7.7
Price/Sales Ratio7.56
Price/Book Ratio5.6
Enterprise/Revenue7.56
Enterprise/EBITDA26.41

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.19
Operating Margin0.53

Management Effectiveness

Return On Assets0
Return On Equity0.15

Income Statement

Revenue525.78B
Revenue/Share224.21
Gross Profit410.2B
EBITDA149.68B
Net Income109.29B
Diluted EPS45.6

Balance Sheet

Total Cash261.23B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share302.21

Price History

52-Week Change-10.73
52-Week High1,922.7
52-Week Low1,548
Moving Average 50 Days1,623.33
Moving Average 200 Days1,684.99

Statistics

Average Volume2.48M
Shares Outstanding2.4B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate16
Trailing Annual Dividend Yield0.94
Payout Ratio0
Last Split Factor2:1
Last Split DateJuly 29, 2013